8th Avenue and C Street, Salt Lake City, UT, 84143 · (801) 408-1100
Beds
256
FY 2024
Star rating
5 of 5
Patient survey: 4 of 5
Net patient revenue
$366.1M
FY 2024
Net income
$9.6M
Patient care margin -1.8%
Discharges
9,744
Occupancy 49.2%
Clinicians
704
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2024 | $366.1M | $372.9M | -1.8% | $9.6M | 9,744 | $17.3M | 11.1% | 15.4% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for heart failure patients | 10.8% | US median 11% |
| Hospital-wide death rate within 30 days | 3.2% | US median 3.9% |
| Death rate for pneumonia patients | 16.4% | US median 15.2% |
| Readmission rate for COPD | 19.8% | US median 19.8% |
| Readmission rate for heart failure | 21.4% | US median 21.3% |
| Readmission rate after hip or knee replacement | 4.8% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2023 | $344.4M | $355.3M | -3.2% | -$1.2M | 8,173 | $16.3M | 11.9% | 15.6% |
| 2022 | $307.0M | $323.9M | -5.5% | -$9.5M | 6,737 | $13.4M | 14.1% | 11.2% |
| 2021 | $296.6M | $293.5M | 1.1% | $8.1M | 7,367 | $14.7M | 14.0% | 10.5% |
| 2020 | $261.8M | $273.7M | -4.5% | $9.8M | 7,700 | $14.9M | 14.0% | 10.9% |
| US median 5.8% |
| Readmission rate for pneumonia | 17.2% | US median 17.2% |
| Complications after hip or knee replacement | 4.2% | US median 4.1% |
| Serious complications (patient safety composite) | 0.91 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.33 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.62 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 0.00 | US median 0.72 · better |
| MRSA bloodstream infections (ratio to expected) | 0.41 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.23 | US median 0.40 |
| Doctors always communicated well | 83% | US median 79% |
| Nurses always communicated well | 79% | US median 80% |
| Patient survey summary star rating | 4 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 63% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 73% | US median 72% |
| Room and bathroom always clean | 81% | US median 73% |
| Patients who would definitely recommend the hospital | 75% | US median 71% |
| Patients who left the emergency department before being seen | 1% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 176 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 11% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 62% | US median 65% |
| Healthcare workers given the flu vaccine | 92% | US median 79% |
| 34 |
| $94,667.91 |
| $22,705.59 |
| $26,100.04 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 34 | $53,595.03 | $14,730.94 | $14,289.25 |
| DRG 330 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC | 31 | $59,475.00 | $16,411.87 | $18,026.21 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 26 | $22,785.04 | $8,685.15 | $7,681.44 |
| DRG 897 ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC | 23 | $40,767.00 | $8,260.43 | $7,306.07 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 22 | $54,391.86 | $12,973.45 | $12,667.88 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 20 | $104,294.60 | $30,703.90 | $40,556.82 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 20 | $42,941.60 | $10,804.85 | $9,973.97 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 17 | $28,725.18 | $10,337.29 | $9,867.73 |
| DRG 291 HEART FAILURE AND SHOCK WITH MCC | 16 | $42,017.13 | $10,861.38 | $10,022.34 |
| DRG 834 ACUTE LEUKEMIA WITH MCC | 14 | $292,104.86 | $70,335.71 | $63,231.97 |
| DRG 682 RENAL FAILURE WITH MCC | 11 | $43,963.64 | $11,757.91 | $11,457.18 |
| DRG 378 GASTROINTESTINAL HEMORRHAGE WITH CC | 11 | $32,450.36 | $9,711.09 | $7,294.77 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5115 Level 5 Musculoskeletal Procedures | 284 | 267 | $9,915.71 | $10,771.69 |
| APC 5302 Level 2 Upper GI Procedures | 196 | 176 | $1,313.63 | $1,444.50 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 122 | 93 | $1,991.20 | $2,141.49 |
| APC 5361 Level 1 Laparoscopy and Related Services | 77 | 76 | $3,901.84 | $4,357.80 |
| APC 5183 Level 3 Vascular Procedures | 59 | 53 | $2,120.76 | $2,405.01 |
| APC 5374 Level 4 Urology and Related Services | 56 | 48 | $2,353.90 | $2,629.24 |
| APC 8011 Comprehensive Observation Services | 50 | 50 | $1,953.63 | $2,090.36 |
| APC 5362 Level 2 Laparoscopy and Related Services | 50 | 50 | $7,427.95 | $8,164.45 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 40 | 39 | $1,070.21 | $1,219.56 |
| APC 5116 Level 6 Musculoskeletal Procedures | 34 | 33 | $15,027.09 | $15,762.73 |
| APC 5114 Level 4 Musculoskeletal Procedures | 27 | 27 | $5,105.19 | $5,338.75 |
| APC 5375 Level 5 Urology and Related Services | 27 | 25 | $3,693.10 | $3,917.51 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Becton, Dickinson and Company BDX | 3 | $291K |
| Abbvie Inc. ABBV | 3 | $187K |
| Syndax Pharmaceuticals, Inc. SNDX | 13 | $112K |
| Novartis Pharmaceuticals Corporation NVS | 2 | $57K |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $40K |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $15K |
| Incyte Corporation INCY | 20 | $14K |
| Zimmer Biomet Holdings, Inc. ZBH | 3 | $11K |
| Kite Pharma, Inc. GILD | 2 | $9,540 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $5,000 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Lds Hospital is a nonprofit short-term acute care hospital in Salt Lake City, UT with 256 beds, part of Intermountain Health and a 5-star overall rating.
Lds Hospital in Salt Lake City, UT has 256 beds (fiscal year 2024 cost report); 250 beds are certified for Medicare. It discharged 9,744 inpatients that year, with 49.2% of its beds in use on average.
In fiscal year 2024 (ending 2024-12-31), Lds Hospital reported net patient revenue of $366.1M and operating expenses of $372.9M, a margin on patient care of -1.8%. After other income and expenses its net income was $9.6M (2.5% of revenue), so it made a profit that year.
Lds Hospital is part of Intermountain Health, a health system with 29 hospitals based in Salt Lake City, UT. It is a nonprofit hospital.
Lds Hospital has an overall rating of 5 out of 5 stars in the official hospital quality ratings. Patients rate it 4 out of 5 stars in the patient survey.
Yes, Lds Hospital provides emergency services.
704 Medicare clinicians list Lds Hospital as a hospital they work at, most often in Nurse Practitioner, Physician Assistant, Internal Medicine.
In 2024, Lds Hospital had 472 Medicare inpatient stays in 15 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 102 stays; Medicare paid $15,196.12 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $745K in payments to Lds Hospital as a teaching hospital ($8,500 general and $736K for research) from 12 companies.